All In Biotech

Drug Trial Radar · NCT02453893

Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia

Double-blind,Double-simulation,Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia

Last checked: Nov 20, 2026Latest source record: May 27, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 288 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

288

Planned (sponsor's estimate)

Start

Nov 2013

Primary completion

Jun 2015

Sponsor

Sponsor type
Industry
First posted
May 27, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This research is a Randomized, double-blind, risperidone-controlled, multicenter clinical study. Chinese subjects with Ischemic Schizophrenia.

Conditions

  • Schizophrenia

Interventions

  • IloperidoneDrug

  • RisperidoneDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the score of Positive and Negative syndrome scale to evaluation the severity of schizophreniaTime frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Mental Health Center

    Shanghai, Shanghai Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.